Indrayani Biotech Ltd — Board Meeting, 26-02-2026: Board Meeting
26-02-2026 | 09:26 pm
26-02-2026 | 09:26 pm
Indrayani Biotech's board approved Q3 FY26 financial results. Consolidated Revenue was ₹35.01 Cr with ₹0.12 Cr profit. Mr. Kunisetty Venkateswara Rao is the new CFO. Company secured ₹5 Cr credit and is expediting its Rights Issue.
No comments yet. Be the first to comment!
